Diversity of Neisseria meningitidis invasive isolates in Italy in the period 2008-2010

Journal of Preventive Medicine and Hygiene

Volumn 53, Issue 2, 2012, Pages 109-112

  Neri, A ^a   Fazio, C ^a   Carannante, A ^a   Mastrantonio, P ^a   Stefanelli, P ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Invasive disease; Molecular characterization; Neisseria meningitidis

Indexed keywords

CEFTRIAXONE; CIPROFLOXACIN; PENICILLIN G; RIFAMPICIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; DRUG DETERMINATION; GENETIC VARIABILITY; GENOTYPE; ITALY; MICROBIAL DIVERSITY; MINIMUM INHIBITORY CONCENTRATION; NEISSERIA MENINGITIDIS; NONHUMAN; PHENOTYPE;

BACTERIAL TYPING TECHNIQUES; GENOTYPE; HUMANS; ITALY; NEISSERIA MENINGITIDIS; PHENOTYPE;

EID: 84864720589     PISSN: 11212233     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Rouphael NG, Stephens DS. Neisseria meningitidis: biology, microbiology, and epidemiology. Methods Mol Biol 2012; 799:1-20.
2. Harrison OB, Brueggemann AB, Caugant DA, et al. Molecular typing methods for outbreak detection and surveillance of invasive disease caused by Neisseria meningitidis, Haemophilus influenzae and Pneumococcus pneumoniae. Microbiology 2011;157:2181-95.
3. Anderson AS, Jansen KU, Eiden J. New frontiers in meningococcal vaccines. Expert Rev Vaccines 2011;10:617-34.
4. http://ecdc.europa.eu/en/healthtopics/meningococcal/Pages/index.aspx
5. Trotter CL, Greenwood BM. Meningococcal carriage in the African meningitis belt. Lancet Infect Dis. 2007;7:797-803. (Pubitemid 350152042)
6. Donnelly J, Medini D, Boccadifuoco G, et al. Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines. Proc Natl Acad Sci USA 2010;107:19490-5.
7. http://www.simi.iss.it/files/Report-MBI.pdf, latest update 24/02/2012.
8. Abdillahi H, Poolman JT. Typing of group-B Neisseria meningitidis with monoclonal antibodies in the whole-cell ELISA. J Med Microbiol 1988;26:177-80.
9. http://www.eucast.org/clinical-breakpoints.
10. http://neisseria.org/nm/typing/mlstdb/.
11. Maiden MC, Bygraves JA, Feil E, et al. Multilocus sequence typing: a portable approach to the identificatiiiooon of clones whithin populations of pathogenic microorganisms. Proc Natl Acad Sci USA 1998;95:3140-5. (Pubitemid 28135868)
12. http://neisseria.org/nm/typing/pora.
13. Vogel U, Claus H. Molecular epidemiology of Neisseria meningitidis. Front Biosci 2003; 8:14-22.
14. Ancona F, Alfonsi V, Caporali M, et al. Pneumococcal conjugate, meningococcal C and varicella vaccination in Italy. Euro Surveill 2007;12:25-8.
15. Rosenstein NE, Perkins BA, Stephens DS, et al. The changing epidemiology of meningococcal disease in the United States, 1992-1996. J Infect Dis 1999;180:1894-901.
16. Ladhani SN, Lucidarme J, Newbold LS, et al. Invasive meningococcal capsular group Y disease, England and Wales, 2007-2009. Emerg Infect Dis 2012;18:63-70.
17. Neri A, Fazio C, Carannante A, et al. Molecular characterization of Neisseria meningitidis B:NT:P1.14/162 clonal complex responsible of invasive meningococcal disease in the north of Italy. Diagn Microbiol Infect Dis 2012;72:370-2.
18. Fazio C, Neri A, Tonino S, et al. Characterisation of Neisseria meningitidis C strains causing two clusters in the north of Italy in 2007 and 2008. Euro Surveill 2009;14:pii: 19179.
19. Neri A, Mignogna G, Fazio C, et al. Neisseria meningitidis rifampicin resistant strains: analysis of protein differentially expressed. BMC Microbiol 2010;10:246.
20. Skoczynska A, Ruckly C, Hong E, et al. Molecular characterization of resistance to rifampicin in clinical isolates of Neisseria meningitidis. Clin Microbiol Infect 2009;15:1178-81.